BlackRock Institutional Trust’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

BlackRock Institutional Trust’s Portfolio OSIR Stock Details OSIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$2.44M	Buy	497,743 +2,832	+0.6%	+$14.5K	﹤0.01%	2987
2016 Q3	$2.46M	Hold	494,911	–	–	﹤0.01%	2974
2016 Q2	$2.52M	Sell	494,911 -17,080	-3%	-$92K	﹤0.01%	2946
2016 Q1	$2.92M	Sell	511,991 -9,727	-2%	-$67.9K	﹤0.01%	2892
2015 Q4	$5.42M	Sell	521,718 -1,213	-0.2%	-$16.5K	﹤0.01%	2682
2015 Q3	$9.66M	Sell	522,931 -88,081	-14%	-$1.7M	﹤0.01%	2322
2015 Q2	$11.9M	Sell	611,012 -26,230	-4%	-$464K	﹤0.01%	2287
2015 Q1	$11.2M	Buy	637,242 +9,100	+1%	+$153K	﹤0.01%	2328
2014 Q4	$10M	Buy	628,142 +3,395	+0.5%	+$45.5K	﹤0.01%	2361
2014 Q3	$7.87M	Sell	624,747 -16,965	-3%	-$242K	﹤0.01%	2466
2014 Q2	$10M	Buy	641,712 +26,093	+4%	+$384K	﹤0.01%	2438
2014 Q1	$8.08M	Buy	615,619 +99,997	+19%	+$1.56M	﹤0.01%	2554
2013 Q4	$8.29M	Sell	515,622 -28,247	-5%	-$450K	﹤0.01%	2536
2013 Q3	$9.05M	Sell	543,869 -6,854	-1%	-$101K	﹤0.01%	2424
2013 Q2	$5.55M	Buy	+550,723	New	+$5.79M	﹤0.01%	2648

Other funds holding OSIR

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

BBA

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

BlackRock Institutional Trust's OSIR Position: Q4 2016 in Review

BlackRock Institutional Trust increased its Osiris Therapeutics, Inc. Common Stock (OSIR) stake by 0.57% in Q4 2016, buying an estimated $14.5K and bringing the position to 497,743 shares worth $2.44M. The position accounts for ﹤0.01% of the portfolio, ranked #2987.

BlackRock Institutional Trust first reported a position in OSIR in Q2 2013 and has held it in 15 quarters since. The position peaked at $11.9M in Q2 2015. 64 funds tracked by Wall St. Rank hold OSIR as of Q4 2016.

BlackRock Institutional Trust held 497,743 shares of Osiris Therapeutics, Inc. Common Stock worth $2.44M as of Q4 2016.
BlackRock Institutional Trust bought 2,832 Osiris Therapeutics, Inc. Common Stock shares in Q4 2016, an estimated $14.5K.
Osiris Therapeutics, Inc. Common Stock made up ﹤0.01% of BlackRock Institutional Trust's portfolio in Q4 2016, its #2987 holding.
BlackRock Institutional Trust first reported a position in Osiris Therapeutics, Inc. Common Stock in Q2 2013 and has held it in 15 quarters since.
BlackRock Institutional Trust's Osiris Therapeutics, Inc. Common Stock position peaked at $11.9M in Q2 2015.
64 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q4 2016.

Based on BlackRock Institutional Trust's 13F filing for Q4 2016, filed 10 Feb 2017.